Table 3.
Univariate and multivariate analysis of determinants of good outcome before and after PSM.
| Before PSM | After PSM | |||||||
|---|---|---|---|---|---|---|---|---|
| mRS (0–1) at 90 days | mRS (0–1) at 90 days | |||||||
| Variables | Unadjusted OR (95% CI) | p-value | Adjusted OR (95% CI) | p-value | Unadjusted OR (95% CI) | p-value | Adjusted OR (95% CI) | p-value |
| Thrombectomy | 4.01 (1.69–9.53) | 0.001 | 4.44 (1.74–11.36) | 0.002 | 3.15 (1.25–7.95) | 0.013 | 3.61 (1.31–9.93) | 0.013 |
| Infarct core ≤15 ml | 3.46 (1.43–8.36) | 0.005 | 3.10 (1.16–8.32) | 0.025 | 4.12 (1.54–11.50) | 0.004 | 3.91 (1.30–11.74) | 0.015 |
| Gender, male | 0.37 (0.16–0.88) | 0.023 | 0.40 (0.16–1.04) | 0.059 | 0.45 (0.17–1.18) | 0.100 | 0.52 (0.18–1.49) | 0.222 |
| Pre-mRS = 1 | 0.17 (0.02–1.55) | 0.159 | 0.35 (0.03–3.71) | 0.038 | 0.17 (0.02–1.74) | 0.131 | 0.37 (0.03–4.16) | 0.417 |
| mRS (0–2) at 90 days | mRS (0–2) at 90 days | |||||||
| Variables | Unadjusted OR (95% CI) | p -value | Adjusted OR (95% CI) | p -value | Unadjusted OR (95% CI) | p -value | Adjusted OR (95% CI) | p -value |
| Thrombectomy | 3.03 (1.16–7.92) | 0.020 | 3.32 (1.16–9.48) | 0.025 | 2.48 (0.89–6.96) | 0.079 | 2.95 (0.92–9.50) | 0.070 |
| Infarct core ≤15 ml | 4.00 (1.61–9.96) | 0.002 | 3.27 (1.22–8.88) | 0.018 | 6.55 (2.22–19.28) | 0.000 | 5.78 (1.81–18.42) | 0.003 |
| Gender, male | 0.46 (0.17–1.20) | 0.106 | 0.58 (0.20–1.63) | 0.299 | 0.44 (0.14–1.35) | 0.144 | 0.59 (0.17–2.04) | 0.405 |
| Pre-mRS = 1 | 0.09 (0.01–0.82) | 0.023 | 0.16 (0.02–1.66) | 0.124 | 0.09 (0.01–0.96) | 0.044 | 0.20 (0.02–2.30) | 0.195 |
Adjusted for sex, Pre-mRS, thrombectomy and infarct core ≤15 ml. PSM, propensity score matching; mRS, modified Rankin Scale; OR, odds ratio; CI, confidence interval.